Fortem Financial Group LLC Purchases New Holdings in The Procter & Gamble Company (NYSE:PG)

Fortem Financial Group LLC acquired a new position in shares of The Procter & Gamble Company (NYSE:PG - Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 3,395 shares of the company's stock, valued at approximately $569,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Itau Unibanco Holding S.A. purchased a new stake in shares of Procter & Gamble during the second quarter valued at approximately $28,000. Fairway Wealth LLC bought a new position in shares of Procter & Gamble during the second quarter worth about $29,000. RPg Family Wealth Advisory LLC acquired a new stake in shares of Procter & Gamble in the third quarter valued at approximately $33,000. Quest Partners LLC bought a new stake in Procter & Gamble during the 2nd quarter valued at $36,000. Finally, Fairfield Financial Advisors LTD acquired a new position in Procter & Gamble during the 2nd quarter valued at about $44,000. Institutional investors and hedge funds own 65.77% of the company's stock.

Procter & Gamble Trading Down 2.7 %

Shares of Procter & Gamble stock traded down $4.52 during trading on Monday, hitting $160.61. The company's stock had a trading volume of 8,728,889 shares, compared to its average volume of 6,462,323. The stock has a market cap of $378.24 billion, a price-to-earnings ratio of 27.69, a price-to-earnings-growth ratio of 3.70 and a beta of 0.45. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The Procter & Gamble Company has a 52 week low of $146.28 and a 52 week high of $180.43. The stock has a 50-day moving average price of $170.21 and a two-hundred day moving average price of $169.85.

Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The company had revenue of $21.74 billion during the quarter, compared to the consensus estimate of $21.99 billion. During the same period last year, the company earned $1.83 earnings per share. The firm's revenue was down .6% compared to the same quarter last year. Equities research analysts anticipate that The Procter & Gamble Company will post 6.94 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were paid a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a yield of 2.51%. The ex-dividend date of this dividend was Friday, October 18th. Procter & Gamble's dividend payout ratio is presently 69.31%.

Wall Street Analysts Forecast Growth

PG has been the subject of several research reports. JPMorgan Chase & Co. raised their price objective on shares of Procter & Gamble from $179.00 to $186.00 and gave the company an "overweight" rating in a research report on Thursday, September 19th. Evercore ISI upped their price target on shares of Procter & Gamble from $180.00 to $183.00 and gave the company an "outperform" rating in a research report on Monday, October 21st. Morgan Stanley increased their target price on shares of Procter & Gamble from $174.00 to $191.00 and gave the stock an "overweight" rating in a research report on Monday, October 21st. Barclays lowered Procter & Gamble from an "overweight" rating to an "equal weight" rating and set a $163.00 target price on the stock. in a research report on Monday, September 30th. Finally, Piper Sandler began coverage on shares of Procter & Gamble in a research note on Tuesday, September 24th. They issued a "neutral" rating and a $174.00 target price for the company. Eight research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $180.45.

Insider Transactions at Procter & Gamble

In other news, CEO R. Alexandra Keith sold 1,992 shares of the business's stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $170.00, for a total transaction of $338,640.00. Following the completion of the sale, the chief executive officer now owns 13,783 shares in the company, valued at $2,343,110. The trade was a 12.63 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Balaji Purushothaman sold 12,800 shares of the stock in a transaction on Thursday, October 24th. The stock was sold at an average price of $168.99, for a total value of $2,163,072.00. Following the completion of the transaction, the insider now owns 11,566 shares in the company, valued at approximately $1,954,538.34. This represents a 52.53 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 75,439 shares of company stock valued at $13,317,460. Corporate insiders own 0.18% of the company's stock.

Procter & Gamble Company Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.